Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer-a state of the art review

被引：19

作者：

Heidegger, Isabel ^{[1
]}

Kesch, Claudia ^{[2
]}

Kretschmer, Alexander ^{[3
]}

Tsaur, Igor ^{[4
]}

Ceci, Francesco ^{[5
]}

Valerio, Massimo ^{[6
]}

Tilki, Derya ^{[7
,8
,9
]}

Marra, Giancarlo ^{[10
]}

Preisser, Felix ^{[11
]}

Fankhauser, Christian D. ^{[12
]}

Zattoni, Fabio ^{[13
]}

Chiu, Peter ^{[14
]}

Puche-Sanz, Ignacio ^{[15
]}

Olivier, Jonathan ^{[16
]}

van den Bergh, Roderik C. N. ^{[17
]}

Kasivisvanathan, Veeru ^{[18
]}

Pircher, Andreas ^{[19
]}

Virgolini, Irene ^{[20
]}

Gandaglia, Giorgio ^{[21
,22
]}

机构：

[1] Med Univ Innsbruck, Dept Urol, Urol, A-6020 Innsbruck, Austria

[2] Essen Univ Hosp, Dept Urol, Essen, Germany

[3] Ludwig Maximilians Univ Munchen, Dept Urol, Munich, Germany

[4] Mainz Univ Med, Dept Urol & Pediat Urol, Mainz, Germany

[5] IRCCS, Div Nucl Med, IEO European Inst Oncol, Milan, Italy

[6] Lausanne Univ Hosp, Dept Urol, Lausanne, Switzerland

[7] Univ Med Ctr Hamburg Eppendorf, Martini Klin Prostate Canc Ctr, Hamburg, Germany

[8] Univ Med Ctr Hamburg Eppendorf, Dept Urol, Hamburg, Germany

[9] Koc Univ Hosp, Dept Urol, Istanbul, Turkey

[10] Univ Torino, San Giovanni Battista Hosp, Dept Urol, Turin, Italy

[11] Univ Hosp Frankfurt, Dept Urol, Frankfurt, Germany

[12] Luzerner Kantonssspital, Luzern, Switzerland

[13] Azienda Sanitaria Univ Integrata Udine, Urol Unit, Udine, Italy

[14] Chinese Univ Hong Kong, Fac Med, Dept Surg, Hong Kong, Peoples R China

[15] Univ Granada, Hosp Univ Virgende las Nieves, Biohlth Res Inst, Dept Urol, Granada, Spain

[16] CHUV Lausanne, Dept Urol, Lausanne, Switzerland

[17] Antonius Hosp, Dept Urol, Utrecht, Netherlands

[18] UCL, Div Surg & Intervent Sci, London, England

[19] Med Univ Innsbruck, Dept Internal Med 5, Hematol & Oncol, Innsbruck, Austria

[20] Med Univ Innsbruck, Dept Nucl Med, Innsbruck, Austria

[21] IRCCS Osped San Raffaele, Urol Res Inst, Div Oncol, Milan, Italy

[22] IRCCS Osped San Raffaele, Urol Res Inst, Unit Urol, Milan, Italy

来源：

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | 2022年 / 14卷

关键词：

177Lu-PSMA-617 radioligand therapy; biomarkers; mCRPC; LU-177-PSMA-617 RADIOLIGAND THERAPY; VISCERAL METASTASES; ANTIGEN; PREDICTORS; SURVIVAL; PSMA; EXPRESSION; OUTCOMES; TUMOR;

D O I：

10.1177/17588359221081922

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Radioligand therapy with Lutetium-177 (177Lu)-Prostate-specific membrane antigen (PSMA) has shown to prolong survival in metastatic castration resistant prostate cancer (mCRPC). One of the major challenges for clinicians in the future is to select those patients who would benefit most from this therapy to position it in the treatment landscape of mCRPC. This, in turn, will lead to the delivery of personalized therapies. In this narrative review article we summarize recent studies investigating both predictive and prognostic clinical, imaging-based, and molecular biomarkers to predict treatment response to 177Lu-PSMA-617 radioligand therapy with the aim of identifying men who should be considered for this approach. Of note, the evidence on the role of biomarkers currently relies on small retrospective trials and their validation in larger prospective cohorts is necessary before these results can be translated in the clinical practice.

引用

页数：10

共 51 条

[1] The impact of the extent of the bone involvement on overall survival and toxicity in mCRPC patients receiving [177Lu]Lu-PSMA-617: a WARMTH multicentre study [J].

Ahmadzadehfar, Hojjat ;

Matern, Ralf ;

Baum, Richard P. ;

Seifert, Robert ;

Kessel, Katharina ;

Boegemann, Martin ;

Kratochwil, Clemens ;

Rathke, Hendrik ;

Ilhan, Harun ;

Svirydenka, Hanna ;

Sathekge, Mike ;

Kabasakal, Levent ;

Yordanova, Anna ;

Garcia-Perez, Francisco Osvaldo ;

Kairemo, Kalevi ;

Maharaj, Masha ;

Paez, Diana ;

Virgolini, Irene ;

Rahbar, Kambiz .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (12) :4067-4076

[2] Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial) [J].

Ahmadzadehfar, Hojjat ;

Rahbar, Kambiz ;

Baum, Richard P. ;

Seifert, Robert ;

Kessel, Katharina ;

Boegemann, Martin ;

Kulkarni, Harshad R. ;

Zhang, Jingjing ;

Gerke, Carolin ;

Fimmers, Rolf ;

Kratochwil, Clemens ;

Rathke, Hendrik ;

Ilhan, Harun ;

Maffey-Steffan, Johanna ;

Sathekge, Mike ;

Kabasakal, Levent ;

Osvaldo Garcia-Perez, Francisco ;

Kairemo, Kalevi ;

Maharaj, Masha ;

Paez, Diana ;

Virgolini, Irene .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (01) :113-122

[3] Predictors of overall survival in metastatic castration-resistant prostate cancer patients receiving [177Lu]Lu-PSMA-617 radioligand therapy [J].

Ahmadzadehfar, Hojjat ;

Schlolaut, Stephan ;

Fimmers, Rolf ;

Yordanova, Anna ;

Hirzebruch, Stefan ;

Schlenkhoff, Carl ;

Gaertner, Florian C. ;

Awang, Zool Hilmi ;

Hauser, Stefan ;

Essler, Markus .

ONCOTARGET, 2017, 8 (61) :103108-103116

[4] Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up [J].

Andriole, Gerald L. ;

Crawford, E. David ;

Grubb, Robert L., III ;

Buys, Saundra S. ;

Chia, David ;

Church, Timothy R. ;

Fouad, Mona N. ;

Isaacs, Claudine ;

Kvale, Paul A. ;

Reding, Douglas J. ;

Weissfeld, Joel L. ;

Yokochi, Lance A. ;

O'Brien, Barbara ;

Ragard, Lawrence R. ;

Clapp, Jonathan D. ;

Rathmell, Joshua M. ;

Riley, Thomas L. ;

Hsing, Ann W. ;

Izmirlian, Grant ;

Pinsky, Paul F. ;

Kramer, Barnett S. ;

Miller, Anthony B. ;

Gohagan, John K. ;

Prorok, Philip C. .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (02) :125-132

[5] Clinical Outcomes of 177Lu-PSMA Radioligand Therapy in Earlier and Later Phases of Metastatic Castration-Resistant Prostate Cancer Grouped by Previous Taxane Chemotherapy [J].

Barber, Thomas W. ;

Singh, Aviral ;

Kulkarni, Harshad R. ;

Niepsch, Karin ;

Billah, Baki ;

Baum, Richard P. .

JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (07) :955-962

[6] Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer [J].

Barinka, C. ;

Rojas, C. ;

Slusher, B. ;

Pomper, M. .

CURRENT MEDICINAL CHEMISTRY, 2012, 19 (06) :856-870

[7] The Effect of Total Tumor Volume on the Biologically Effective Dose to Tumor and Kidneys for 177Lu-Labeled PSMA Peptides [J].

Begum, Nusrat J. ;

Thieme, Anne ;

Eberhardt, Nina ;

Tauber, Robert ;

D'Alessandria, Calogero ;

Beer, Ambros J. ;

Glatting, Gerhard ;

Eiber, Matthias ;

Kletting, Peter .

JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (06) :929-933

[8] 177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer [J].

Braeuer, Axel ;

Grubert, Lena Sophie ;

Roll, Wolfgang ;

Schrader, Andres Jan ;

Schaefers, Michael ;

Boegemann, Martin ;

Rahbar, Kambiz .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (10) :1663-1670

[9] Prediction nomogram for 68Ga-PSMA-11 PET/CT in different clinical settings of PSA failure after radical treatment for prostate cancer [J].

Ceci, Francesco ;

Bianchi, Lorenzo ;

Borghesi, Marco ;

Polverari, Giulia ;

Farolfi, Andrea ;

Briganti, Alberto ;

Schiavina, Riccardo ;

Brunocilla, Eugenio ;

Castellucci, Paolo ;

Fanti, Stefano .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (01) :136-146

[10] EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer [J].

Cornford, Philip ;

van den Bergh, Roderick C. N. ;

Briers, Erik ;

Van den Broeck, Thomas ;

Cumberbatch, Marcus G. ;

De Santis, Maria ;

Fanti, Stefano ;

Fossati, Nicola ;

Gandaglia, Giorgio ;

Gillessen, Silke ;

Grivas, Nikolaos ;

Grummet, Jeremy ;

Henry, Ann M. ;

van der Kwast, Theodorus H. ;

Lam, Thomas B. ;

Lardas, Michael ;

Liew, Matthew ;

Mason, Malcolm D. ;

Moris, Lisa ;

Oprea-Lager, Daniela E. ;

van der Poel, Henk G. ;

Rouviere, Olivier ;

Schoots, Ivo G. ;

Tilki, Derya ;

Wiegel, Thomas ;

Willemse, Peter-Paul M. ;

Mottet, Nicolas .

EUROPEAN UROLOGY, 2021, 79 (02) :263-282

← 1 2 3 4 5 6 →